clip-1 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
clip-1 antibody; M01A8.2 antibody; CAP-Gly domain-containing linker protein 1 homolog antibody
Target Names
clip-1
Uniprot No.

Q&A

Here’s a structured FAQ for researchers working with clip-1 antibodies, organized by research complexity and grounded in methodological rigor:

Advanced Research Questions

How to resolve clip-1 antibody cross-reactivity in multiplex assays?

  • Strategies:

    • Epitope Mapping: Identify clip-1’s linear/conformational epitopes via SPOT synthesis or HDX-MS .

    • Competitive Blocking: Pre-incubate antibody with recombinant clip-1 protein (≥10-fold molar excess) .

    • Cross-Species Validation: Compare reactivity in human, mouse, and primate models to pinpoint non-specific interactions .

What computational tools predict clip-1 antibody-antigen binding dynamics?

  • Approach:

    ToolApplicationOutput
    PyMolStructural alignmentCDR-epitope interactions
    HADDOCKDocking simulationsBinding energy (ΔG)
    RosettaAffinity maturationMutational impact on KD
    Use in silico models to guide mutagenesis studies for affinity optimization .

How to address discordant clip-1 expression data across platforms (e.g., WB vs. scRNA-seq)?

  • Troubleshooting Framework:

    • Technical Variability: Compare antibody lots, fixation methods, and detection substrates .

    • Biological Context: Assess post-translational modifications (e.g., phosphorylation) that may alter epitope accessibility .

    • Multi-Omics Integration: Correlate protein-level data with transcriptomics via LASSO regression to identify confounding factors .

Methodological Best Practices

How to engineer clip-1 antibodies for in vivo imaging?

  • Humanization Workflow:

    • CDR grafting onto human frameworks (e.g., IgG1) to reduce immunogenicity .

    • Introduce stabilizing mutations (e.g., S239D/I332E) to enhance FcγR binding for PET/SPECT .

    • Validate pharmacokinetics in NSG mice (t1/2 > 7 days preferred) .

Standardizing clip-1 antibody validation for multi-center studies

  • Collaborative Protocol:

    • Distribute aliquots from a single lot to all sites.

    • Use reference samples (high/low clip-1 expression) for inter-lab calibration.

    • Adopt MIAPE (Minimum Information About a Proteomics Experiment) guidelines for reporting .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.